Duhay Francis 4
4 · enVVeno Medical Corp · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
enVVeno Medical (NVNO) Director Duhay Francis Sells 140 Shares
What Happened
- Duhay Francis, a director of enVVeno Medical Corp (NVNO), sold 140 shares in an open-market transaction on March 12, 2026. The sale was reported at a weighted-average price of $11.52 per share for a total proceeds of approximately $1,613. This was a sale (not a purchase or option exercise).
Key Details
- Transaction date: 2026-03-12; filing date: 2026-03-13 (filed timely).
- Shares sold: 140; weighted-average price: $11.52; total proceeds: ~$1,613.
- Execution detail: trade executed in multiple trades at prices from $11.5200 to $11.5450 (footnote F2). Reporting person can provide full per-trade details upon request.
- Planned sale: completed under a Rule 10b5-1 trading plan adopted by the reporting person in June 2025 (footnote F1).
- Shares owned after the transaction: not specified in the supplied filing excerpt.
Context
- This was a pre-planned sale under a 10b5-1 plan, which typically means trades were made according to a previously established schedule rather than timed to recent company news. Sales are common and do not, by themselves, indicate an insider's negative view of the company.
Insider Transaction Report
Form 4
Duhay Francis
Director
Transactions
- Sale
Common Stock
[F1][F2]2026-03-12$11.52/sh−140$1,613→ 2,502 total
Footnotes (2)
- [F1]This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.
- [F2]This transaction was executed in multiple trades during the day at prices ranging from $11.5200 to $11.5450, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.
Signature
/s/ Francis Duhay|2026-03-13